When.com Web Search

  1. Ads

    related to: new bipolar medication

Search results

  1. Results From The WOW.Com Content Network
  2. Lumateperone - Wikipedia

    en.wikipedia.org/wiki/Lumateperone

    Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [2] It is developed by Intra-Cellular Therapies, licensed from Bristol ...

  3. Treatment of bipolar disorder - Wikipedia

    en.wikipedia.org/wiki/Treatment_of_bipolar_disorder

    A recent large-scale study found that severe depression in patients with bipolar disorder responds no better to a combination of antidepressant medications and mood stabilizers than it does to mood stabilizers alone and that antidepressant use does not hasten the emergence of manic symptoms in patients with bipolar disorder.

  4. List of psychiatric medications by condition treated - Wikipedia

    en.wikipedia.org/wiki/List_of_psychiatric...

    This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.

  5. Bipolar Disorder: 4 Types & What You Need to Know About Them

    www.aol.com/bipolar-disorder-4-types-know...

    Medications for Bipolar Disorder. Treatment for bipolar disorder is still a developing field. And some of the go-to medications for regulating bipolar disorder symptoms, like depressive symptoms ...

  6. Mood stabilizer - Wikipedia

    en.wikipedia.org/wiki/Mood_stabilizer

    Lithium – Lithium is the "classic" mood stabilizer, the first to be approved by the US FDA, and still popular in treatment. Therapeutic drug monitoring is required to ensure lithium levels remain in the therapeutic range: 0.6 to 0.8 or 0.8–1.2 mEq/L (or millimolar).

  7. Cariprazine - Wikipedia

    en.wikipedia.org/wiki/Cariprazine

    Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] which is used in the treatment of schizophrenia and bipolar disorder. [9] It is also prescribed as an add-on treatment for bipolar depression [10] and major depressive disorder. [6]

  1. Ads

    related to: new bipolar medication